Researchers at the University of California, San Diego School of Medicine have identified a mechanism that explains why people with the hepatitis C virus get liver disease and why the virus is able to persist in the body ...
Apr 15, 2014
0
0
Given omega 6 fatty acid's reputation for promoting cancer—at least in animal studies—researchers are examining the role that antioxidants play in blocking the harmful effects of this culprit, found in many cooking oils. ...
Apr 4, 2014
0
0
Harvard stem cell scientists studying the effect of nitric oxide on liver growth and regeneration appear to have serendipitously discovered a markedly improved treatment for liver damage caused by acetaminophen toxicity, ...
Feb 20, 2014
0
0
(Medical Xpress)—University of Adelaide researchers have identified a key step for the future prevention of liver failure resulting from taking too much of the everyday painkiller paracetamol (also known as acetaminophen).
Feb 3, 2014
0
0
US regulators said Wednesday they are urging doctors to cease prescribing drugs that contain more than 325 milligrams of acetaminophen per tablet due to concerns over liver damage.
Jan 15, 2014
0
0
A ground-breaking scan that can identify and help to treat liver disease, could make painful and invasive liver biopsies a thing of the past, thanks to a trial being led by the University of Birmingham.
Nov 26, 2013
0
0
(HealthDay)—The U.S. Food and Drug Administration has approved a new drug for chronic hepatitis C infection that some experts hope will cut down on side effects from current therapies.
Nov 25, 2013
0
0
Viral infections are the primary cause of liver inflammation or hepatitis, affecting hundreds of millions of people all over the world, and they represent a public health problem worldwide. The acute condition can cause irreversible ...
Nov 8, 2013
0
0
An experimental hepatitis C drug from Johnson & Johnson has won unanimous support from government experts who say the medication should be approved to treat patients infected with the liver-destroying virus.
Oct 24, 2013
0
0
U.S. Food and Drug Administration advisers on Friday unanimously voted in favor of a highly anticipated hepatitis C drug from Gilead Sciences that holds promise for millions infected with the liver-destroying virus.
Oct 23, 2013
0
0
